
    
      Subjects will be assigned to one of the two arms of the study, after having been deemed
      eligible during the screening visit in random double-blind design. Subjects will be evaluated
      for a 4 week period.

      OBJECTIVES

        -  To assess the effects of F0434 and gabapentin alone on neuropathic pain and Quality Of
           Life (QOL) of subjects with diabetic neuropathy through a current and validated
           neuropathic pain scale along with the QOL questionnaire.
    
  